Inventor · disambiguated record
Lars Wortmann
Also filed as: WORTMANN LARS
14 granted patents·28 pending applications·76 citations·filing 2003–2023
90Inventor score
Top patents by PatentIndex Score
42 records- 0196US9549932B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2016·Granted Jan 24, 2017·26 cites·30 claims
- 0293US10729680B25-substituted 2-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2017·Granted Aug 4, 2020·10 cites·14 claims
- 0389US9993484B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2015·Granted Jun 12, 2018·4 cites·9 claims
- 0488US11998539B2Substituted aminoquinolones as DGKalpha inhibitors for immune activationBAYER AG·Filed 2022·Granted Jun 4, 2024·1 cites·24 claims
- 0586US7511059B2Thiazolidinones, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2006·Granted Mar 31, 2009·14 cites·15 claims
- 0685US11529356B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2020·Granted Dec 20, 2022·1 cites·20 claims
- 0785US10772893B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2018·Granted Sep 15, 2020·2 cites·12 claims
- 0880US9382255B2Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitorsBayer Pharma AG·Filed 2013·Granted Jul 5, 2016·3 cites·9 claims
- 0978US7504410B2Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agentsSCHERING AG·Filed 2003·Granted Mar 17, 2009·13 cites·22 claims
- 1072US9540392B2ThienopyrimidinesBayer Pharma AG·Filed 2013·Granted Jan 10, 2017·2 cites·10 claims
- 1160US2025340546A1Hsd17b13 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1257US12478621B2Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Granted Nov 25, 2025·0 cites·17 claims
- 1354US2010048891A1Metasubstituted thiazolidinones, their manufacture and use as a drugSCHULZE KLAUSE·Filed 2009·Application pending·0 cites
- 1454US2024174683A1Map4k1 inhibitorsBAYER AG·Filed 2022·Application pending·0 cites
- 1552US9556181B2Substituted pyrazolopyrimidinylamino-indazolesBayer Pharma AG·Filed 2014·Granted Jan 31, 2017·0 cites·9 claims
- 1652US2016159816A1Substituted thienopyrimidines and pharmaceutical use thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1750US2015252047A1Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperproliferative diseasesBayer Pharma AG·Filed 2013·Application pending·0 cites
- 1850US2023064809A1Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Application pending·0 cites
- 1949US2009075987A1Alkylacetylene substituted acyltryptophanolsWORTMANN LARS·Filed 2008·Application pending·0 cites
- 2048US2023062100A1Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Application pending·0 cites
- 2148US2008275083A12,3,4,9-tetrahydro-1h-carbazolesWORTMANN LARS·Filed 2008·Application pending·0 cites
- 2248US2008255117A1SulfonyltryptophanolsWORTMANN LARS·Filed 2008·Application pending·0 cites
- 2348US2009069328A1Alpha-alkyl substituted n-acyltryptophanolsWORTMANN LARS·Filed 2008·Application pending·0 cites
- 2447US9675612B2Substituted thiazolopyrimidinesBayer Pharma AG·Filed 2014·Granted Jun 13, 2017·0 cites·11 claims
- 2547US2021017174A1Identification and use of erk5 inhibitorBAYER AG·Filed 2019·Application pending·0 cites
- 2647US2008287493A1Arylmethylen substituted n-acyl-y-aminoalcoholsWORTMANN LARS·Filed 2008·Application pending·0 cites
- 2746US2007015759A1Metasubstituted thiazolidinones, their manufacture and use as a drugSCHULZE VOLKER K·Filed 2005·Application pending·0 cites
- 2846US2009082372A1Arylmethylene Substituted N-Acyl-Beta-Amino AlcoholsWORTMANN LARS·Filed 2008·Application pending·0 cites
- 2946US2009069321A1Cyanomethyl substituted n-acyl tryptaminesWORTMANN LARS·Filed 2008·Application pending·0 cites
- 3045US2008207728A1Bicyclic acyltryptophanolsWORTMANN LARS·Filed 2007·Application pending·0 cites
- 3145US2016297833A1Thienopyrimidines as mknk1 and mknk2 inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3245US2007037862A1Thiazolidinones, their production and use as pharmaceutical agentsSIEMEISTER GERHARD·Filed 2004·Application pending·0 cites
- 3344US2008221195A11,2-diarylacetylene derivatives of acyltryptophanolsWORTMANN LARS·Filed 2007·Application pending·0 cites
- 3444US2016159789A1Substituted pyrazolopyridinesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3544US2007060573A1AcyltryptophanolsWORTMANN LARS·Filed 2006·Application pending·0 cites
- 3643US9296757B2Substituted benzothienopyrimidinesBayer Pharma AG·Filed 2013·Granted Mar 29, 2016·0 cites·9 claims
- 3743US2015133426A1Substituted pyrrolopyrimidinesBayer Pharma AG·Filed 2013·Application pending·0 cites
- 3842US2015218173A1Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperfoliferative disordersBayer Pharma AG·Filed 2013·Application pending·0 cites
- 3940US2015080438A16,7-Dihydro-5H-benzo[7]annulene derivatives, processes for their preparation, pharmaceutical products comprising them and their use for preparing medicamentsBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 4037US2007010565A1New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agentsPRIEN OLAF·Filed 2006·Application pending·0 cites
- 4136US2013252890A16,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicamentsWINTERMANTEL TIM·Filed 2011·Application pending·0 cites
- 4234US2007010566A1Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agentsPRIEN OLAF·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Wortmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →